Citation 68811

OTSUKA,T: SHIBATA,T: TSURUMI,Y: TAKASE,S: OKUHARA,M: TERANO,H: KOHSAKA,M: IMANAKA,H:. (1992). A NEW ANGIOGENESIS INHIBITOR, FR-111142.. 45(3)

Citation Details

TitleA NEW ANGIOGENESIS INHIBITOR, FR-111142.
AuthorsOTSUKA,T: SHIBATA,T: TSURUMI,Y: TAKASE,S: OKUHARA,M: TERANO,H: KOHSAKA,M: IMANAKA,H:
Year1992
Volume45
Issue3

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (1)

Scolecobasidium arenarium (HYPHOMYCETES)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
None
2
ANGIOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
ACTIVE
3
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
INACTIVE
4
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
INACTIVE
5
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
INACTIVE
6
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
INACTIVE
7
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
INACTIVE
8
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
INACTIVE
9
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
INACTIVE
10
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
ACTIVE
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
EQUIVOCAL
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
EQUIVOCAL
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
EQUIVOCAL
14
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
ACTIVE
15
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
WEAK ACTIVITY
16
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SPIRO(2.5)-OCT-6-YL-4-5-4(3)-5(S)-DIHYDROXY-HEX-TRANS-2-ENOATE,5-METHOXY-4-(2(R)-METHYL-3-(3(R)-METHYL-2-BUTENYL)OXIRANYL)-1-OXA:
ACTIVE
Show SPARQL Queries (1)